Akili Interactive Labs raises $30.5 million to develop FDA-approved brain training videogame for ADHD

.

Videogame Mak­er Seeks to Treat ADHD (The Wall Street Journal):

“Doc­tors don’t usu­al­ly pre­scribe videogame play. But one com­pa­ny, which has just raised $30.5 mil­lion from ven­ture-cap­i­tal investors, hopes to change that.

Boston-based Akili Inter­ac­tive Labs Inc. is devel­op­ing a videogame it believes could replace pills as a treat­ment for atten­tion-deficit hyper­ac­tiv­i­ty disorder.

It plans to use the funds to run a large-scale clin­i­cal tri­al with the aim of win­ning approval from the U.S. Food and Drug Admin­is­tra­tion in 2017…

Akili isn’t the first com­pa­ny to apply gam­ing to the improve­ment of cog­ni­tive func­tion. How­ev­er, it hopes to set itself apart from oth­ers such as Cogmed, owned by Pear­son PLC, and San Fran­cis­co-based Lumos Labs Inc. by get­ting approval from the FDA so doc­tors could pre­scribe it.”

To learn more:

• Arti­cle: Can brain train­ing work? Yes, if it meets these 5 conditions
• Info­graph­ic on the Dig­i­tal Brain Health Mar­ket 2012–2020
• Slid­edeck: